is there any report/research paper or anything availalble on the "WHY SERUM FERRITIN or IRON LOAD LEVELS GET HIGH IN PATIENTS OF THALLASEMIA MAJOR?"

Reading File

Finding Sources

Searching PubMed

thalassemia major iron overload serum ferritin mechanism

Searching the Web

why serum ferritin iron overload high thalassemia major mechanisms research

Reading File

Searching PubMed

thalassemia major iron overload hepcidin erythropoiesis transfusion

Reading Web Page

why iron overload ferritin high thalassemia major mechanisms

Reading Article

Finding Sources

Reading File

I now have comprehensive information from authoritative textbooks and peer-reviewed literature. Here is a thorough, well-cited answer:

Why Serum Ferritin / Iron Load Gets High in Thalassemia Major

Yes — there is extensive research and authoritative textbook coverage on this topic. The mechanisms are well-understood and fall into two major categories, with a key molecular pathway (hepcidin) running through both.

The Two Root Causes

1. Repeated Blood Transfusions (Primary driver in Thalassemia Major)

Every unit of packed red blood cells delivers approximately 200–250 mg of iron into the body. Thalassemia major patients require transfusions every 2–4 weeks lifelong, as their bone marrow cannot produce functioning hemoglobin due to absent or severely deficient β-globin chains.

The problem: The human body has no physiological pathway to excrete excess iron. Iron is lost only through cell shedding (skin, gut epithelium, menstruation) — roughly 1 mg/day. With each transfusion adding hundreds of milligrams, iron accumulates relentlessly in:

The reticuloendothelial (RE) macrophage system → raises serum ferritin (ferritin is released from macrophages)
Liver parenchymal cells → hepatic iron overload
Heart muscle → cardiac siderosis (leading cause of death)
Endocrine glands (pituitary, pancreas, thyroid)

In transfused patients, iron is preferentially loaded into the RE system, which directly drives ferritin production and release. This is why serum ferritin is markedly elevated in well-transfused thalassemia major patients — Tietz Textbook of Laboratory Medicine, 7th Ed.

2. Ineffective Erythropoiesis + Increased GI Iron Absorption (Even without transfusions)

Even non-transfused or minimally transfused patients develop iron overload. The mechanism involves:

Step-by-step cascade (from Goldman-Cecil Medicine, 26th Ed.):

Globin chain imbalance → excess free α-chains precipitate in erythroid precursors in bone marrow → membrane damage → premature death of red cell precursors = ineffective erythropoiesis
Massive expansion of the erythroid marrow signals the body that more iron is needed
Erythroid precursors overproduce Erythroferrone (ERFE) and GDF-15 (Growth Differentiation Factor-15)
ERFE and GDF-15 suppress the hepatic hormone hepcidin by blocking BMP (Bone Morphogenetic Protein) signaling in the liver
With hepcidin suppressed → ferroportin (the only iron export protein on gut enterocytes and macrophages) is upregulated → massively increased dietary iron absorption from the gut
This produces iron overload even without a single transfusion

The Central Molecular Villain: Hepcidin Suppression

Hepcidin is the master regulator of iron homeostasis. In β-thalassemia:

Hepcidin is inappropriately low despite the body being iron-overloaded
This is because the erythropoietic signal (via ERFE/GDF-15) overrides the iron-sensing signal
The result: gut iron absorption continues unchecked, and macrophages keep releasing stored iron

A 2022 review in Biomedicines (PMID: 35052868) specifically identified STAT and SMAD signaling pathways as the molecular routes by which hepcidin re-expression could be restored as a therapeutic target — confirming hepcidin suppression as the mechanistic core of iron overload in β-thalassemia.

A 2021 review in J Cell Physiology (PMID: 33372284) by Srole & Ganz (Ganz is the discoverer of hepcidin) confirmed: "In ineffective erythropoiesis, pathological overproduction of ERFE by an expanded population of erythroblasts suppresses hepcidin and causes iron overload, even in non-transfused patients."

Why Serum Ferritin Specifically Rises

Serum ferritin is a surrogate marker of body iron stores. It rises because:

Macrophages in the RE system engulf the iron from transfused, senescent red cells → store it as ferritin → leak ferritin into the bloodstream
Liver cells (hepatocytes) accumulate excess iron → synthesize more ferritin → serum ferritin reflects hepatic iron burden
Ferritin synthesis is directly driven by intracellular labile iron levels (Fe²⁺ elevates ferritin mRNA translation via Iron Response Element/Iron Regulatory Protein system)
Chronic tissue damage and inflammation from iron toxicity further elevate ferritin (ferritin is also an acute phase reactant)

Important caveat: In thalassemia major, serum ferritin overestimates RE-based iron and may not accurately reflect parenchymal (hepatocyte/cardiac) iron — liver biopsy or MRI T2* remains the gold standard — Yamada's Textbook of Gastroenterology, 7th Ed.

Key Research Papers Available

PMID	Title	Evidence
35052868	STAT & SMAD signaling, hepcidin re-expression in β-thalassemia (Biomedicines, 2022)	Review
33372284	Erythroferrone structure, function & physiology — iron homeostasis (J Cell Physiol, 2021)	Review
PMC6142532	Iron overload in thalassemia: different organs at different rates (Blood Adv, 2018)	Review
PMC3968466	Serum ferritin levels in multi-transfused β-thalassemia major patients	Clinical Study
33565577	Correlation of hepcidin and serum ferritin in thalassemia patients (Biosci Rep, 2021)	Clinical Study

Summary Diagram of Mechanisms

β-THALASSEMIA MAJOR
        │
        ▼
α-chain excess → Ineffective Erythropoiesis
        │
        ├──── Transfusion therapy (every 2-4 wks)
        │           │
        │           └──► ~250 mg Fe per unit
        │                    │
        │                    └──► Accumulates in RE system
        │                                │
        │                                └──► ↑ Serum Ferritin
        │
        └──── Massive erythroid expansion
                    │
                    └──► ↑ Erythroferrone (ERFE) + ↑ GDF-15
                                │
                                └──► Suppress HEPCIDIN
                                            │
                                            └──► ↑ Ferroportin activity
                                                        │
                                                        └──► ↑ GI iron absorption
                                                                    │
                                                                    └──► ↑ Iron overload
                                                                                │
                                                                                └──► ↑ Serum Ferritin

Both pathways converge on iron overload → high serum ferritin. In thalassemia major, the transfusional route dominates, but ineffective erythropoiesis/hepcidin suppression adds to it significantly.

This is a shared conversation. Sign in to Orris to start your own chat.